Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Silexion Therapeutics Corp - Ordinary Shares
(NQ:
SLXN
)
2.585
+0.075 (+2.99%)
Streaming Delayed Price
Updated: 12:47 PM EDT, Jul 22, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Silexion Therapeutics Corp - Ordinary Shares
< Previous
1
2
3
4
Next >
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
↗
November 20, 2024
Via
Benzinga
What's Going On With Silexion Therapeutics Shares Wednesday?
↗
November 20, 2024
Silexion Therapeutics shares are moving higher on Wednesday after the company reported that Guangzhou Sino-Israel bio-industry investment fund holds a decent stake in the company.
Via
Benzinga
US Stocks Mostly Lower; Target Posts Downbeat Earnings
↗
November 20, 2024
Via
Benzinga
Ilan Hadar, CEO of Silexion Therapeutics Corp. (NASDAQ: SLXN), to Present at NobleCon20
November 14, 2024
Via
Investor Brand Network
Silexion Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update
November 14, 2024
Significant advancements in clinical and preclinical programs targeting KRAS-driven cancers; company advancing pipeline with focus on challenging oncology indications.
Via
News Direct
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
↗
November 05, 2024
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
↗
October 23, 2024
Via
Benzinga
Silexion Therapeutics to Present at 2024 Maxim Healthcare Virtual Summit
October 09, 2024
Silexion Therapeutics to Present at 2024 Maxim Healthcare Virtual Summit
Via
News Direct
12 Health Care Stocks Moving In Friday's After-Market Session
↗
October 04, 2024
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
↗
October 02, 2024
Via
Benzinga
Silexion Investigational Pancreatic Cancer Treatment Shows Promise In Animal Studies
↗
October 01, 2024
Silexion Therapeutics' stock surged after the company revealed preclinical findings for SIL-204, its siRNA candidate.
Via
Benzinga
Market Alert: Silexion Therapeutics (NASDAQ: SLXN) Sees Record Volumes Following Breakthrough Preclinical Data for SIL-204
October 01, 2024
New data from preclinical studies for SIL-204 seems to have sparked the markets attention for Silexion Therapeutics.
Via
News Direct
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
↗
October 01, 2024
Via
Benzinga
Silexion Therapeutics Unveils Promising Preclinical Data for SIL-204 Just Days After New LODER Data: Advancing the Fight Against Pancreatic Cancer
October 01, 2024
Via
AB Newswire
Silexion Therapeutics Reports Breakthroughs From SIL-204 Preclinical Studies
October 01, 2024
From
Silexion Therapeutics Corp.
Via
Business Wire
Silexion Therapeutics Stock Trades Higher, Trial Data For Pancreatic Cancer Patients Shows Promise
↗
September 24, 2024
Silexion Therapeutics sees surge in trading volume after revealing new findings from a Phase 2 trial of LODER in pancreatic cancer patients.
Via
Benzinga
Silexion Therapeutics Reports Promising Phase 2 Data for Non-Resectable Pancreatic Cancer Treatment
September 24, 2024
Via
AB Newswire
Silexion Therapeutics Announces Significant New Data from Phase 2 Trial of LODER™ in Non-Resectable Pancreatic Cancer
September 24, 2024
From
Silexion Therapeutics
Via
Business Wire
Industry Update: 3 Exciting Precision Oncology Players to Watch Following Summit’s Meteoric Rise: Silexion, Nuvectis, Scorpian
September 19, 2024
Via
AB Newswire
Industry Update: 3 Exciting Precision Oncology Players to Watch Following Summit’s Meteoric Rise: Silexion, Nuvectis, Scorpian
September 19, 2024
Summit Therapeutics' rise could signal emerging opportunities in precision oncology such Nuvectis Pharma (NASDAQ: NVCT), Silexion (NASDAQ:SLXN), and Scorpion leading the charge.
Via
News Direct
Why Dave & Buster's Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket
↗
September 11, 2024
Via
Benzinga
Why Oracle Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket
↗
September 10, 2024
Via
Benzinga
PESG Releases Report on Silexion Therapeutics: Pioneering RNAi Technology in the Fight Against KRAS-Driven Cancers
September 09, 2024
From
PESG Research
Via
Business Wire
Why Recursion Pharmaceuticals Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
↗
September 03, 2024
Via
Benzinga
< Previous
1
2
3
4
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
